LOTTE BIOLOGICS Signs Antibody Manufacturing Contract with Ottimo Pharma

Contributed by: PR Newswire

Images

PR Newswire associated0

PR Newswire associated1

Tags

LOTTE-Ottimo-Pharma

More Like This

PR Newswire associated0

LOTTE BIOLOGICS Holds Groundbreaking for Songdo Bio Campus

PR Newswire associated0

LOTTE Holdings establishes a new Healthcare and Biopharmaceutical Corporate Venture Capital

WuXi Biologics Announces Research Service Agreement with BioNTech on Discovering Investigational Monoclonal Antibodies for Developing Next-Generation Therapeutic Product Candidates

Merck invests €70 million to triple its antibody-drug conjugate (ADC) manufacturing capacity and upgrade 3200 m2 at its BioConjugation Center of Excellence in St. Louis, Missouri, USA. (Photo: Business Wire)

Merck Invests €70 Million to Expand ADC Manufacturing for Novel Cancer Therapies

PR Newswire associated0

GBI Biomanufacturing and Allterum Therapeutics Announce Strategic Collaboration to Manufacture Therapeutic Antibody for Clinical Trials

Biocytogen and Gilead Enter Into a Multi-Target Antibody Collaboration Agreement

EMA Approves Biocon Biologics' New mAbs Facility in India and Renews GMP Certifications for India and Malaysia Sites

Biocytogen Enters into Multi-Target Antibody Agreement with Neurocrine Biosciences